NCI-CCC GI Tumor Board Question   

Questions discussed in this category

In a patient who is not a surgical candidate, do you offer concurrent carbo/taxol rather than 5FU/oxaliplatin? 

Does the advent of more effective therapies like peptide receptor radioligand therapy (PRRT) and capecitabine and temozolomide (CAPTEM) dampen enthusi...

If so, how many cycles would you give? Both the MAGIC and FLOT trials showed difficulty with administering adjuvant chemotherapy.

The patient went straight to gastrectomy for clinical T1 gastric adenocarcinoma, but post-op was up-graded to T4 disease.   Both ARTIST and Inte...

Upfront surgery vs neoadjuvant therapy? And if neoadjuvant therapy, which regimen? Patient has a good PS.

How would the new data presented at ASCO GI 2021 from from Alliance A021501 influence your answer?

Papers discussed in this category


J. Clin. Oncol., 2013 Aug 26

Proceedings of the National Academy of Sciences of the United States of America, 2015-11-03

Oncologist, 2020 Mar 10

Semin Diagn Pathol, 2016 Dec 23

Lancet Oncol., 2015-09-01

British journal of cancer, 2005-03-14

Case Rep Oncol, 2020 Jan 21

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012-07-01

The New England journal of medicine, 2001-09-06

Lancet, 2019 Apr 11

Pancreas, 2017-07

Pancreas, 2020 Jan

Surg Oncol Clin N Am, 2020 Oct 20

Scand J Gastroenterol, 2019 Aug 01

J Am Coll Surg, 2017 Jan 11

The New England journal of medicine, 2018-07-05

Lancet (London, England), 2018-03-24

J Gastroenterol, 2019 Nov 12

Am Heart J, 2010 Sep 18

N Engl J Med,

Lancet (London, England), 2017-01-07

The Lancet. Oncology, 2019-02

JAMA Oncol, 2020 Dec 10

Hepatology, 2019 Oct 14

N Engl J Med, 2020 May 14